NAS:NVCR (N/A) Also trade in: Germany

NovoCure Ltd

$ 49.31 -2.05 (-3.99%)
Volume: 363,087 Avg Vol (1m): 563,365
Market Cap $: 4.72 Bil Enterprise Value $: 4.61 Bil
P/E (TTM): 0.00 P/B: 36.96
Earnings Power Value -23.9
Net Current Asset Value 0.97
Tangible Book 1.33
Projected FCF 0
Median P/S Value 36.8
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1.72
Cash-To-Debt ranked higher than
52.68% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
NVCR: 1.72
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 1.45, Med: 2.11, Max: 508.36
Current: 1.72
1.45
508.36
Equity-to-Asset 0.34
Equity-to-Asset ranked lower than
74.49% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
NVCR: 0.34
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.33, Med: 0.49, Max: 0.83
Current: 0.34
0.33
0.83
Debt-to-Equity 1.18
Debt-to-Equity ranked lower than
81.69% of 142 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
NVCR: 1.18
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.72, Max: 1.41
Current: 1.18
0
1.41
Debt-to-EBITDA -10.38
Debt-to-EBITDA ranked lower than
100.00% of 109 companies
in the Medical Instruments & Supplies industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
NVCR: -10.38
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -10.38, Med: -0.56, Max: 0
Current: -10.38
-10.38
0
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.73
DISTRESS
GREY
SAFE
Beneish M-Score -1.20
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -132.39%
WACC 16.82%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -10.07
Operating Margin ranked lower than
76.12% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
NVCR: -10.07
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -622.25, Med: -226.72, Max: -10.07
Current: -10.07
-622.25
-10.07
Net Margin % -20.42
Net Margin ranked lower than
79.10% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
NVCR: -20.42
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -746.89, Med: -248.15, Max: -20.42
Current: -20.42
-746.89
-20.42
ROE % -48.08
ROE ranked lower than
81.82% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
NVCR: -48.08
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -67.07, Med: -58.07, Max: -45.04
Current: -48.08
-67.07
-45.04
ROA % -16.77
ROA ranked lower than
78.16% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
NVCR: -16.77
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -52.6, Med: -42.85, Max: -16.77
Current: -16.77
-52.6
-16.77
ROC (Joel Greenblatt) % -96.75
ROC (Joel Greenblatt) ranked lower than
78.43% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
NVCR: -96.75
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -1469.27, Med: -937.94, Max: -96.75
Current: -96.75
-1469.27
-96.75
3-Year Total Revenue Growth Rate 95.70
3-Year Revenue Growth Rate ranked higher than
97.65% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
NVCR: 35.4
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 35.4, Med: 88.8, Max: 110.3
Current: 35.4
35.4
110.3
3-Year Total EBITDA Growth Rate 41.10
3-Year EBITDA Growth Rate ranked higher than
80.00% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 426.6, Med: 10, Min: -759
NVCR: 59.3
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -13.4, Med: 32.5, Max: 59.3
Current: 59.3
-13.4
59.3
3-Year EPS w/o NRI Growth Rate 42.70
3-Year EPS w/o NRI Growth Rate ranked higher than
53.55% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 253, Med: 12.9, Min: -782.7
NVCR: 42.7
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 14.8, Max: 42.7
Current: 42.7
0
42.7

» NVCR's 30-Y Financials

Financials (Next Earnings Date: 2019-07-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:NVCR

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3845
Compare SZSE:002901 TSE:7732 NYSE:HYH NAS:MMSI NAS:NXTM FRA:PHH2 ROCO:1565 NAS:IRTC XTER:GXI SZSE:002414 SZSE:300061 XKLS:7153 TSE:3593 TSE:7730 ASX:ANN NAS:ATRI SZSE:300595 SZSE:300677 NYSE:GKOS NAS:OSUR
Traded in other countries 038.Germany
Address Grenville Street, No. 4 The Forum, St. Helier, JEY, JE2 4UF
NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.

Ratios

Current vs industry vs history
PB Ratio 36.96
PB Ratio ranked lower than
96.37% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
NVCR: 36.96
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 3.32, Med: 14.22, Max: 44.18
Current: 36.96
3.32
44.18
PS Ratio 17.01
PS Ratio ranked lower than
88.02% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
NVCR: 17.01
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 5.78, Med: 12.72, Max: 68.11
Current: 17.01
5.78
68.11
Price-to-Free-Cash-Flow 1264.31
Price-to-Free-Cash-Flow ranked lower than
100.00% of 74 companies
in the Medical Instruments & Supplies industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
NVCR: 1264.31
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 1082.56, Med: 1233.85, Max: 1438.97
Current: 1264.31
1082.56
1438.97
Price-to-Operating-Cash-Flow 432.55
Price-to-Operating-Cash-Flow ranked lower than
100.00% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
NVCR: 432.55
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 370.35, Med: 422.11, Max: 492.28
Current: 432.55
370.35
492.28
EV-to-EBIT -199.62
EV-to-EBIT ranked lower than
100.00% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
NVCR: -199.62
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -225.5, Med: -22.6, Max: -3
Current: -199.62
-225.5
-3
EV-to-EBITDA -320.87
EV-to-EBITDA ranked lower than
100.00% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
NVCR: -320.87
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -362.5, Med: -24.8, Max: -3.1
Current: -320.87
-362.5
-3.1
EV-to-Revenue 17.14
EV-to-Revenue ranked lower than
85.43% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
NVCR: 17.14
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 5, Med: 12.2, Max: 62.8
Current: 17.14
5
62.8
Current Ratio 4.73
Current Ratio ranked higher than
77.50% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
NVCR: 4.73
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 4.73, Med: 6.57, Max: 11.76
Current: 4.73
4.73
11.76
Quick Ratio 4.39
Quick Ratio ranked higher than
81.09% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
NVCR: 4.39
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 4.39, Med: 6.07, Max: 11.64
Current: 4.39
4.39
11.64
Days Inventory 97.15
Days Inventory ranked lower than
62.94% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
NVCR: 97.15
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 97.07, Med: 126.27, Max: 156.13
Current: 97.15
97.07
156.13
Days Sales Outstanding 53.17
Days Sales Outstanding ranked higher than
52.12% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
NVCR: 53.17
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 27.91, Med: 57.35, Max: 136.75
Current: 53.17
27.91
136.75
Days Payable 133.90
Days Payable ranked higher than
83.44% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
NVCR: 133.9
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 112.93, Med: 220.75, Max: 535.35
Current: 133.9
112.93
535.35

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.10
3-Year Share Buyback Rate ranked lower than
58.04% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
NVCR: -3.1
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -7.4, Med: -6.5, Max: -3.1
Current: -3.1
-7.4
-3.1

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 37.08
Price-to-Tangible-Book ranked lower than
90.42% of 167 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
NVCR: 37.08
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 4.63, Med: 14.49, Max: 42.39
Current: 37.08
4.63
42.39
Price-to-Median-PS-Value 1.34
Price-to-Median-PS-Value ranked higher than
58.75% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
NVCR: 1.34
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.53, Med: 0.97, Max: 4.32
Current: 1.34
0.53
4.32
Earnings Yield (Joel Greenblatt) % -0.50
Earnings Yield (Greenblatt) ranked lower than
67.63% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
NVCR: -0.5
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -33.3, Med: -4.4, Max: -0.4
Current: -0.5
-33.3
-0.4

More Statistics

Revenue (TTM) (Mil) $ 269.25
EPS (TTM) $ -0.6
Beta 2.4
Volatility % 73.6
52-Week Range $ 26.02 - 56.67
Shares Outstanding (Mil) 95.77

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y